These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25288392)

  • 1. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.
    Ranta S; Tuckuviene R; Mäkipernaa A; Albertsen BK; Frisk T; Tedgård U; Jónsson ÓG; Pruunsild K; Gretenkort Andersson N; Winther Gunnes M; Saulyte Trakymiene S; Frandsen T; Heyman M; Ruud E; Helgestad J
    Br J Haematol; 2015 Feb; 168(4):547-52. PubMed ID: 25288392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management.
    Ghanem KM; Dhayni RM; Al-Aridi C; Tarek N; Tamim H; Chan AKC; Saab R; Abboud MR; El-Solh H; Muwakkit SA
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28660695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia - a cohort study from the United Kingdom.
    Musgrave KM; van Delft FW; Avery PJ; Clack RM; Chalmers EA; Qureshi A; Vora AJ; Biss TT
    Br J Haematol; 2017 Nov; 179(4):667-669. PubMed ID: 27392277
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
    Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
    Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
    Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
    Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
    Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
    J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
    Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
    Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
    Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
    Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
    Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral venous sinus thrombosis in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype and further prothrombotic risk factors.
    Wermes C; Fleischhack G; Junker R; Schobess R; Schwabe D; Sykora KW; Nowak-Göttl U
    Klin Padiatr; 1999; 211(4):211-4. PubMed ID: 10472552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
    Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
    Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome.
    Sébire G; Tabarki B; Saunders DE; Leroy I; Liesner R; Saint-Martin C; Husson B; Williams AN; Wade A; Kirkham FJ
    Brain; 2005 Mar; 128(Pt 3):477-89. PubMed ID: 15699061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic Cerebral Sinovenous Thrombosis Associated With L-Asparaginase In Children With Acute Lymphoblastic Leukemia: A Single Institution Experience Over 17 Years.
    Malhotra P; Jain S; Kapoor G
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):e450-e453. PubMed ID: 29554021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study.
    Skipper MT; Rank CU; Jarvis KB; Lynggaard LS; Andrés-Jensen L; Quist-Paulsen P; Semaskeviciene R; Hallböök H; Waitiovaara-Kautto U; Ranta S; Trakymiene S; Abrahamsson J; Huttunen P; Albertsen BK; Schmiegelow K; Tuckuviene R
    EJHaem; 2022 Aug; 3(3):754-763. PubMed ID: 36051071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for Central Nervous System thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre cohort study.
    Duarte X; Esteves S; Neto AM; Pereira F
    Br J Haematol; 2016 Jul; 174(2):280-91. PubMed ID: 27018199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Gustafsson G; Kreuger A; Clausen N; Garwicz S; Kristinsson J; Lie SO; Moe PJ; Perkkiö M; Yssing M; Saarinen-Pihkala UM
    Acta Paediatr; 1998 Nov; 87(11):1151-61. PubMed ID: 9846917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
    Rank CU; Toft N; Tuckuviene R; Grell K; Nielsen OJ; Frandsen TL; Marquart HVH; Albertsen BK; Tedgård U; Hallböök H; Ruud E; Jarvis KB; Quist-Paulsen P; Huttunen P; Wartiovaara-Kautto U; Jónsson ÓG; Trakymiene SS; Griškevičius L; Saks K; Punab M; Schmiegelow K
    Blood; 2018 May; 131(22):2475-2484. PubMed ID: 29661787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral sinovenous thrombosis in a girl with acute lymphoblastic leukaemia carrying the prothrombin G20210A variant].
    González García H; Sacoto Erazo G; Moreno Gómez E; Blanco Quirós A; Fernández Abril MC; Alvarez Guisasola FJ
    An Pediatr (Barc); 2013 Apr; 78(4):263-7. PubMed ID: 23047042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
    Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
    Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis and acute lymphoblastic leukaemia.
    Payne JH; Vora AJ
    Br J Haematol; 2007 Aug; 138(4):430-45. PubMed ID: 17608766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.